Gandeeva Therapeutics

Gandeeva Therapeutics is a biotechnology company and contract research organization with operations in Vancouver, BC, integrating cryogenic electron microscopy and machine learning to develop differentiated therapeutics by targeting and modulating key protein interactions. Gandeeva’s structure-guided drug discovery platform encompasses target prediction and validation (SPOTLIGHT™), hit identification by screening virtual and fragment libraries (HYPERFOCUS™), and lead optimization (CRYO-CADD™). Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (iGlues™) and allosteric inhibitors.